Search research articles
Contact Us
Filters
Showing results (151-160 of 330) with videos related to
Page
of 33
Sort By:
Blood Advances
|
May 8, 2026
Revisiting KIR Restriction and CD94 Expression in Diagnostic Criteria for NK-Large Granular Lymphocytic Leukemia
Jansen N Seheult, Gregory E Otteson, Dragan Jevremovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)
James L Rubenstein, Eric D Hsi, Jeffrey L Johnson, et al.
Leukemia & Lymphoma
|
October 16, 2024
High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy
Jianmin Han, Chad M McCall, Scott Isom, et al.
Blood
|
April 25, 2015
CCMCL1: a new model of aggressive mantle cell lymphoma
Xiaoxian Zhao, Selina Chen-Kiang, Shashirekha Shetty, et al.
Haematologica
|
July 18, 2009
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR
Leticia Quintanilla-Martinez, Julia Slotta-Huspenina, Ina Koch, et al.
Archives of Pathology & Laboratory Medicine
|
June 3, 2006
The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee Study
David M Dorfman, Marilyn M Bui, Raymond R Tubbs, et al.
Genes, Chromosomes & Cancer
|
March 24, 2023
The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms
Hatem Kaseb, Valeria Visconte, Daniel S Socha, et al.
Journal of Clinical Pathology
|
September 24, 2014
Frequency, interobserver reproducibility and clinical significance of equivocal peaks in PCR clonality testing using Euroclonality/BIOMED-2 primers
Il Joong Park, James Bena, Claudiu V Cotta, et al.
Therapeutic Advances in Hematology
|
April 7, 2018
Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant
Joshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 10, 2017
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era
Moaath Mustafa Ali, Lisa Rybicki, Laila Nomani, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 330) with videos related to
Sort By:
Page
of 33
Blood Advances
|
May 8, 2026
Revisiting KIR Restriction and CD94 Expression in Diagnostic Criteria for NK-Large Granular Lymphocytic Leukemia
Jansen N Seheult, Gregory E Otteson, Dragan Jevremovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202)
James L Rubenstein, Eric D Hsi, Jeffrey L Johnson, et al.
Leukemia & Lymphoma
|
October 16, 2024
High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy
Jianmin Han, Chad M McCall, Scott Isom, et al.
Blood
|
April 25, 2015
CCMCL1: a new model of aggressive mantle cell lymphoma
Xiaoxian Zhao, Selina Chen-Kiang, Shashirekha Shetty, et al.
Haematologica
|
July 18, 2009
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR
Leticia Quintanilla-Martinez, Julia Slotta-Huspenina, Ina Koch, et al.
Archives of Pathology & Laboratory Medicine
|
June 3, 2006
The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee Study
David M Dorfman, Marilyn M Bui, Raymond R Tubbs, et al.
Genes, Chromosomes & Cancer
|
March 24, 2023
The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms
Hatem Kaseb, Valeria Visconte, Daniel S Socha, et al.
Journal of Clinical Pathology
|
September 24, 2014
Frequency, interobserver reproducibility and clinical significance of equivocal peaks in PCR clonality testing using Euroclonality/BIOMED-2 primers
Il Joong Park, James Bena, Claudiu V Cotta, et al.
Therapeutic Advances in Hematology
|
April 7, 2018
Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant
Joshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 10, 2017
Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era
Moaath Mustafa Ali, Lisa Rybicki, Laila Nomani, et al.
Page
of 33